Artículos de revistas
Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
Fecha
2014-08Registro en:
Scotti, Leopoldina; Abramovich, Dalhia Nurit; Pascuali, Natalia Marisa; Irusta, Griselda; Meresman, Gabriela Fabiana; et al.; Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.; Elsevier; Journal of Steroid Biochemistry and Molecular Biology; 144; Part B; 8-2014; 392-401
0960-0760
1879-1220
Autor
Scotti, Leopoldina
Abramovich, Dalhia Nurit
Pascuali, Natalia Marisa
Irusta, Griselda
Meresman, Gabriela Fabiana
Tesone, Marta
Parborell, Maria Fernanda Agustina
Resumen
The relationship between human chorionic gonadotropin and ovarian hyperstimulation syndrome (OHSS) is partially mediated by vascular endothelial growth factor A (VEGF). The aim of this study was to investigate the effects of VEGF inhibition on the development of corpora lutea (CL) and cystic structures, steroidogenesis, apoptosis, cell proliferation, endothelial cell area, VEGF receptors (KDR and Flt-1), claudin-5 and occludin levels in ovaries from an OHSS rat model. The VEGF inhibitor used (VEGF receptor-1 (FLT-1)/Fc chimera, TRAP) decreased the concentrations of progesterone and estradiol as well as the percentage of CL and cystic structures in OHSS rats, and increased apoptosis in CL. Endothelial cell area in CL and KDR expression and its phosphorylation were increased, whereas claudin-5 and occludin levels were decreased in the OHSS compared to the control TRAP reversed these parameters. Our findings indicate that VEGF inhibition prevents the early onset of OHSS and decreases its severity in rats.